Neoantigen-specific Adoptive T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoantigen-specific Adoptive T Cell Therapy, covering 2025-07-01 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) [Phase 2, Phase 3]